Meta-Analysis of Randomised Clinical Trials Comparing Idarubicin + Cytarabine with Daunorubicin + Cytarabine as the Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukaemia

BACKGROUND: To determine whether the use of idarubicin+cytarabine (IA) is more effective than the use of daunorubicin+cytarabine (DA) as induction chemotherapy for patients with newly diagnosed acute myeloid leukaemia. METHODS: A computer-based search was performed. Randomised trials comparing IA wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Yang, Yong-Gong, Zhou, Min, Xu, Jing-Yan, Zhang, Qi-Guo, Zhou, Rong-Fu, Chen, Bing, Ouyang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622517/
https://www.ncbi.nlm.nih.gov/pubmed/23593285
http://dx.doi.org/10.1371/journal.pone.0060699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622517/
https://www.ncbi.nlm.nih.gov/pubmed/23593285
http://dx.doi.org/10.1371/journal.pone.0060699

Ejemplares similares